Letters Seroprotection and meningitis C

Meningococcal C booster not recommended by evidence

BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1139 (Published 11 August 2008) Cite this as: BMJ 2008;337:a1139
  1. H Lucy Thomas, specialist registrar in public health1,
  2. Nick Andrews1,
  3. Caroline Trotter1,
  4. Mary Ramsay1,
  5. Elizabeth Miller1
  1. 1Health Protection Agency Centre for Infection, London NW9 5EQ
  1. lucy.thomas{at}hpa.org.uk

    Snape et al recommend that a booster dose of meningococcal group C glycoconjugate vaccine (MenC) be administered to children entering adolescence in the UK in the next five years.1 However, their study did not look for, or provide, any evidence of increasing nasopharyngeal carriage in pre-adolescents, and underestimates the protective effect of herd …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription